Patients with coronary artery disease (CAD) undergoing PCI and stent implantation need to be treated with dual antiplatelet agents (aspirin and P2Y12 antagonists) to reduce the risk of stent thrombosis. The gene discussed is P2RY12; the disease is coronary artery disorder.